Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study.

Sugiyama, Seiko; Yamamoto, Takenobu; Aoyama, Yumi

Sugiyama, Seiko; Yamamoto, Takenobu; Aoyama, Yumi.

Affiliation

Sugiyama S; Department of Dermatology, Kawasaki General Medical Center, Kawasaki Medical School, Okayama, Okayama, Japan; Department of Dermatology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Yamamoto T; Department of Dermatology, Kawasaki General Medical Center, Kawasaki Medical School, Okayama, Okayama, Japan; Department of Dermatology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Aoyama Y; Department of Dermatology, Kawasaki Medical School, Kurashiki, Okayama, Japan. Electronic address: ymaoyama@med.kawasaki-m.ac.jp.

J Am Acad Dermatol ; 86(6): 1387-1390, 2022 06.

Article de En | MEDLINE | ID: mdl-34058280

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pemphigoïde bulleuse / Diabète de type 2 / Inhibiteurs de la dipeptidyl-peptidase IV Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Am Acad Dermatol Année: 2022 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google